These observations indicate that the vast majority of tumors display increased KREMEN2 expression compared with normal tissue and that the increase is even more pronounced when KREMEN1 is upregulated, consistent with the idea that Krm2 may promote the abnormal survival of cancer cells through Krm1 antagonism. This evidence concerns the gene KREMEN2 and cancer.